Image

Functional Evaluation After Breast Reconstruction With a Minimally Invasive Latissimus Dorsi Flap Following Radical Surgery for Breast Cancer.

Recruiting
18 - 80 years of age
Female
Phase N/A

Powered by AI

Overview

This study will quantify the muscle function after breast reconstruction using a minimally invasive latissimus dorsi flap.

The proposed measures (clinical, isokinetic, electrophysiology, function and quality of life questionnaires) allow a precise, multidisciplinary, objective evaluation of the capacity of the latissimus dorsi muscle before surgery, 3 months and 6 months after surgery. A function deficit is expected (decreased moment of adduction and internal rotation) 3 months after surgery and a return to the preoperative state 6 months after surgery.

Eligibility

  • Inclusion Criteria:
    1. Patient managed for unilateral MR (immediate or secondary) by MSLD after therapeutic mastectomy.
    2. Breast assessment (Mammography + ultrasound +/- breast MRI) normal dating less than 6 months
    3. Age between 18 and 80 years old
    4. Signature of free and informed consent
      • Exclusion Criteria:
    5. Patient with metastasis or disease progression
    6. Patient whose general condition does not allow her to answer a questionnaire or perform physical and functional measurements (neurocognitive disorders and/or neuro-orthopedic disorders)
    7. Patient with a poor understanding of the French language
    8. Patient having presented a failure of a first breast reconstruction (failure of DIEP, prosthesis removal)
    9. Patient not eligible for MR secondary to cancer (prophylactic mastectomy) or for which the flap was intended to cover loss of substance and not reconstruction
    10. Patient with a history of contralateral MR (all techniques combined)
    11. Patient with a history of contralateral breast cancer
    12. Patient does not have internet access to be able to connect to the "Exolis" software

Study details

Breast Cancer

NCT05278741

Centre Georges Francois Leclerc

25 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.